Chiatali O. Doke, Ranjit S. Tiwari, Vijay B. Todekar, Abhijeet P. Mane, Viraj S. Sawant, Ganesh V. Sawant
Chiatali O. Doke, Ranjit S. Tiwari, Vijay B. Todekar, Abhijeet P. Mane, Viraj S. Sawant, Ganesh V. Sawant
Department of Pharmacology, JBVP’s Vidyaniketan Collage of Pharmacy, Lakhewadi, Tal: Indapur, Dist: Pune Maharashtra, India 413103.
Volume - 15,
Issue - 2,
Year - 2023
Sauces are frequently administered in combination with remedial medicines, raising the eventuality of condiment- medicine relations. An expansive review of the literature linked reported condiment- medicine relations with clinical significance, numerous of which are from case reports and limited clinical compliances. Cases have been published reporting enhanced anticoagulation and bleeding when cases on long- term warfarin remedy also took Salvia miltiorrhiza (danshen). Allium sativum (garlic) dropped the area under the tube attention- time wind (AUC) and maximum tube attention of saquinavir, but not ritonavir and paracetamol (acetaminophen), in levies. A. sativum increased the clotting time and transnational normalised rate of warfarin and caused hypoglycaemia when taken with chlorpropamide. Ginkgo biloba (ginkgo) caused bleeding when combined with warfarin or aspirin (acetylsalicylic acid), raised blood pressure when combined with a thiazide diuretic and indeed caused coma when combined with trazodone in cases. These sauces are frequentlyco-administered with remedial medicines raising the eventuality of medicine – condiment relations, which may have important clinical significance grounded on an adding number of clinical reports of similar interactions. The commerce of medicines with herbal drugs is a significant safety concern, especially for medicines with narrow remedial indicators (e.g. warfarin and digoxin). Because the pharmacokinetics and/ or pharmacodynamics of the medicine may be altered by combination with herbal remedies, potentially severe and maybe indeed life- hanging adverse responses may do. Because of the clinical significance of medicine relations with sauces, it's important to identify medicines and composites in development that may interact with herbal drugs. Timely identification of similar medicines using proper in vitro and in vivo approaches may have important counteraccusations for medicine development.
Cite this article:
Chiatali O. Doke, Ranjit S. Tiwari, Vijay B. Todekar, Abhijeet P. Mane, Viraj S. Sawant, Ganesh V. Sawant. Herb Drug Interaction in Antibiotic Drug, Antiulcer Drug, Antihypertensive Drug, Antidiabetic Drug, Anticancer Drug. Research Journal of Science and Technology. 2023; 15(2):119-6. doi: 10.52711/2349-2988.2023.00020
Chiatali O. Doke, Ranjit S. Tiwari, Vijay B. Todekar, Abhijeet P. Mane, Viraj S. Sawant, Ganesh V. Sawant. Herb Drug Interaction in Antibiotic Drug, Antiulcer Drug, Antihypertensive Drug, Antidiabetic Drug, Anticancer Drug. Research Journal of Science and Technology. 2023; 15(2):119-6. doi: 10.52711/2349-2988.2023.00020 Available on: https://rjstonline.com/AbstractView.aspx?PID=2023-15-2-8
1. Mathur A. Who owns traditional knowledge? Working Paper No. 96, Indian Council for Research on International Economic Relations; 2003. p. 1-33.
2. Agrawal OP, Raju PS. In: Abdin MZ, Abroi YP, editors. Global market of herbal products: Opportunities for India. Traditional system of medicine. Narosa Publishing House: New Delhi, India; 2006. p. 5-10.
3. Wakdikar S. Global health care challenge: Indian experiences and new prescriptions. Electronic J Biotechnol 2004; 7:214-20.
4. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 1998; 28:1569-75.
5. Ramakrishnappa K. Biodiversity and the Ecosystem Approach in Agriculture, Forestry and Fisheries. New York, USA: 2003. Impact of Cultivation and Gathering of Medicinal Plants on Biodiversity: Case studies from India. United Nations Publications: p. 210-5.
6. Newall CA, Anderson LA, Phillipson JD. Herbal Medicines. A Guide for Health-Care Professionals. London: Pharmaceutical Press; 1996. [Google Scholar]
7. Fetow CW, Avila JR. Complementary and Alternative Medicines. PA: Springhouse; 1999. [Google Scholar]
8. Moore, L.B. et al.St. John’s wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc. Natl. Acad. Sci. U. S. A.2000; 97:7500–750.2
9. Durr, D. et al. St John’s wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin. Pharmacol. Ther.2000; 68:598–604.
10. Hennessy, M. et al. St John’s Wort increases expression of Pglycoprotein: implications for drug interactions. Br. J. Clin. Pharmacol. 2002; 53:75–82.
11. Rendic,S. Summary of information on mortal CYP enzymes mortal P450 metabolism data. medicine MetabRev. 2002; 34; 83 – 448. 4. Goodwin,B. et al. Regulation of the mortal CYP2B6 gene by the nuclear pregnane X receptor. Mol. Pharmacol. 2001; 60427 – 431.
12. Kaminsky,L.S. and Zhang,Z.Y.( 1997) mortal P450 metabolism of warfarin. Pharmacol. Ther.1997; 7367 – 74. 23. Lehmann,J.M. et al. The mortal orphan nuclear receptor PXR is actuated by composites that regulate CYP3A4 gene expression and cause medicine relations.J. Clin. Invest.1998; 1021016 – 1023.
13. Chang CL, Lin Y, Bartolome AP, Chen YC, Chiu SC, Yang WC. Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds. Evid Based Complement Altern Med eCAM. 2013; 2013:378657.
14. Mishra R, Mohd Shuaib S, Shiravan S, Mishra PS. A review on herbal antidiabetic drugs. J App Pharma Sci. 2011; 01:235–7.
15. Rhoades KR. Prescribed medications and OTCs: interactions and theming issues. Diabetes Spectrum. 2002; 15:256–261. Chan FK, Graham DY. Prevention of non-steroidal anti-inflammatory drug gastrointestinal complications reviews and recommendation based on risk assessment. Aliment Pharmacal There 2004; 19(10): 1051-1061.
16. Chan FK, Graham DY. Prevention of non-steroidal anti-inflammatory drug gastrointestinal complications reviews and recommendation based on risk assessment. Aliment Pharmacol Ther 2004; 19(10): 1051-1061.
17. Marshall BJ. "Helicobacter Pioneers: Firsthand accounts from the scientists who discovered helicobacter. Edn 3, Vol. I, Blackwell Science Asia Pty Ltd., Victoria, 2002, 1882–1992.
18. Marshall BJ. "Helicobacter Pioneers: Firsthand accounts from the scientists who discovered helicobacter. Edn 3, Vol. I, Blackwell Science Asia Pty Ltd., Victoria, 2002, 1882–1992 IAJPS 2022, 09 (5), 335 -344 Kavita Malviya Et al. IAJPS 2022, 09 (5), 335 -344 Kavita Malviya Et al.
19. Akinyemi A. J., Ademiluyi A. O., Oboh G. (2013). Aqueous extracts of two varieties of ginger (Zingiber officinale) inhibit angiotensin I-converting enzyme, iron(II), and sodium nitroprusside-induced lipid peroxidation in the rat heart in vitro. J. Med. Food 16, 641–646. 10.1089/jmf.2012.0022 [PubMed] [CrossRef] [Google Scholar]
20. Chen JK, Puente L. Interactions recognition and prevention of herb-drug, Medical Acupuncture A Journal For Physicians By Physicians, 1998 / 1999,10(2).
21. Budzinski JW, Foster BC, et al. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures, Phytomedicine, 2000,7(4): 273-282
22. Asdaq SM, Inamdar MN. The potential for interaction of hydrochlorothiazide with garlic in rats, Chem. Biol. Interact, 2009,181: 472–479.
23. Bano G, Raina RK, Zutshi U et al. Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers, Eur J Clin Pharmacol, 1991,41(6): 615-7.
24. Asdaq SMB, Inamdar MN, et al. Interaction of propranolol with garlic in Biochemical and Histological Changes in rat, Iranian Journal of Pharmaceutical Research, 2009,8(3): 201-20.
25. Spanakis M, Vizirianakis IS, et al. Pharmacokinetic Interaction between Losartan and Rhodiola rosea in Rabbits, Pharmacology, 2013 Jan 17,91(1-2): 112-116.
26. Wang XD, Li JL, et al. Rapid and simultaneous determination of nifedipine and dehydronifedipine in human plasma by liquid chromatography–tandem mass spectrometry: Application to a clinical herb–drug interaction study, J. Chromatogr. Biomed. Appl, 2007,852: 534–544.
27. Wright CI, Van-Buren L et al. Herbal medicines as diuretics: A review of the scientific evidence, Journal of Ethnopharmacology, 2007,114: 1–31.
28. Shah SU, Anjum S, et al. Use of diuretics in cardiovascular disease:(2) hypertension. Postgrad Med J, 2004,80: 271- 276.
29. Hardman JG, Limbird LE, Gilman, AG, The pharmacological basis of therapeutics, 11th edition, McGraw- Hill, New Delhi, 2006, 845.
30. Rahelic D. 7th edition of Idf diabetes Atlas-call for immediate action. Lijec Vjesn. 2016;138(1–2):57–8.
31. Chang HY, Wallis M, Tiralongo E. Use of complementary and alternative medicine among people living with diabetes: literature review. J Adv Nurs. 2007;58(4):307–19
32. Patel DK, Prasad SK, Kumar R, Hemalatha S. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed. 2012;2(4):320–30.
33. Okoli CO, Obidike IC, Ezike AC, Akah PA, Salawu OA. Studies on the possible mechanisms of antidiabetic activity of extract of aerial parts of Phyllanthus niruri. Pharm Biol. 2011;49(3):248–55.
34. Hong SH, Heo JI, Kim JH, Kwon SO, Yeo KM, Bakowska-Barczak AM, Kolodziejczyk P, Ryu OH, Choi MK, Kang YH, et al. Antidiabetic and Beta cell-protection activities of purple corn anthocyanins. Biomol Ther (Seoul). 2013;21(4):284–9
35. Gray AM, Flatt PR. Actions of the traditional anti-diabetic plant, Agrimony eupatoria (agrimony): efects on hyperglycaemia, cellular glucose metabolism and insulin secretion. Br J Nutr. 1998;80(1):109–14
36. Yimam M, Zhao J, Corneliusen B, Pantier M, Brownell LA, Jia Q. UP780, a chromone-enriched aloe composition improves insulin sensitivity. Metab Syndr Relat Disord. 2013;11(4):267–75.
37. Bunyapraphatsara N, Yongchaiyudha S, Rungpitarangsi V, Chokechaijaroenporn O. Antidiabetic activity of Aloe vera L. juice II. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomed Int J Phytother Phytopharmacol. 1996;3(3):245–8.
38. Yu BC, Chen WC, Cheng JT. Antihyperclycaemic effect of andrographolide in streptozotocin-induced diabetic rats. Planta Med. 2003;69:1075–9.
39. Yu BC, Chen WC, Cheng JT. Antihyperclycaemic effect of andrographolide in streptozotocin-induced diabetic rats. Planta Med. 2003;69:1075–9.
40. Pan Y, Abd-Rashid BA, Ismail Z, Ismail R, Mak JW, Pook PC, Er HM, Ong CE. In vitro determination of the effect of Andrographis paniculata extracts and andrographolide on human hepatic cytochrome P450 activities. J Nat Med. 2011;65(3–4):440–7.
41. Cho WC, Chung WS, Lee SK, Leung AW, Cheng CH, Yue KK. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efcacies in streptozotocin-induced diabetic rats. Eur J Pharmacol. 2006;550(1–3):173–9.
42. Yoon SH, Han EJ, Sung JH, Chung SH. Anti-diabetic effects of compound K versus metformin versus compound K-metformin combination therapy in diabetic db/db mice. Biol Pharm Bull. 2007;30(11):2196–200.
43. Al-Omaria IL, Affb FU, Salhaba AS. Therapeutic effect and possible herb drug interactions of ginger (Zingiberofcinale Roscoe, Zingiberaceae) crude extract with glibenclamide and insulin. Pharmacognosy Comm. 2012;2:12–20.
44. Australian Institute of Health and Welfare. Cardiovascular disease, diabetes and chronic kidney disease-Australian facts: mortality. Cardiovascular, diabetes and chronic kidney disease, vol. 1. Canberra: AIHW; 2014.
45. Nasri H, Shirzad H, Baradaran A, Rafeian-Kopaei M. Antioxidant plants and diabetes mellitus. J Res Med Sci. 2015;20(5):491–502.
46. World Health Organization The Top 10 Causes of Death. [(accessed on 18 May 2021)]. Available online: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
47. World Health Organization Thailand Fact Sheets. 2021. [(accessed on 18 May 2021)]. Available online: http://gco.iarc.fr/today/data/factsheets/populations/764-thailand-fact-sheets.pdf
48. World Health Organization Cancer. 2021. [(accessed on 18 May 2021)]. Available online: http://www.who.int/news-room/fact-sheets/detail/cancer
49. American Cancer Society Cancer Treatment and Survivorship Facts and Figures. 2019–2021. [(accessed on 18 May 2021)]. Available online: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-treatment-and-survivorship-facts-and-figures/cancer-treatment-and-survivorship-facts-and-figures-2019-2021.pdf
50. Balis F.M. Pharmacokinetic drug interactions of commonly used anticancer drugs. Clin. Pharm. 1986;11:223–235. doi: 10.2165/00003088-198611030-00004. [PubMed] [CrossRef] [Google Scholar].
51. Feng, Y; Wang, N; Zhu, M; Feng, Y; Li H and Tsao, S (2011), “Recent Progress on Anticancer Candidates in Patents of Herbal Medicinal Products; Recent Patents on Food”, Nutrition and Agriculture, 3 30-48
52. Rodeiro, I; Magarino, Y; Ocejo, O; Garrido, G and Delgado, R (2008), “Use of natural products in anti-cancer alternative therapy: risk of interactions with conventional anticancer drugs; Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas, 7 (6), 332-344.
53. Lalla, JK (2005), “Herbal medicines revisited”, The Pharma Review, 12, 101- 105.